Purification of recombinant virus-like particles of porcine circovirus type 2 capsid protein using ion-exchange monolith chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 991, Issue , 2015, Pages 21-28

  Zaveckas, Mindaugas ^a   Snipaitis, Simas ^a   Pesliakas, Henrikas ^a   Nainys, Juozas ^a   Gedvilaite, Alma ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Ion exchange chromatography; Monolith; Porcine circovirus type 2; Virus like particles

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; DIAGNOSIS; ION CHROMATOGRAPHY; IONS; NUCLEIC ACIDS; POLYSACCHARIDES; PORE SIZE; PURIFICATION; RECOMBINANT PROTEINS; SELF ASSEMBLY; VIRUSES; YEAST;

CATION EXCHANGES; CHROMATOGRAPHIC PURIFICATION; HOST CELL PROTEIN; ION EXCHANGE CHROMATOGRAPHY; MONOLITH; MONOLITHIC SUPPORTS; PORCINE CIRCOVIRUS TYPE 2; VIRUS-LIKE PARTICLES;

ION EXCHANGE;

CAPSID PROTEIN; HEPARIN; SEPHAROSE; NANOPARTICLE; RECOMBINANT PROTEIN;

ARTICLE; CATION EXCHANGE; CELL LYSATE; CIRCOVIRUS; CIRCOVIRUS TYPE 2; ELECTRON MICROSCOPY; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIRUS LIKE AGENT; VIRUS PURIFICATION; WESTERN BLOTTING; YEAST CELL; ANIMAL; GENETIC TRANSFORMATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PIG; SACCHAROMYCES CEREVISIAE; ULTRASTRUCTURE; VIRION; VIROLOGY;

EUKARYOTA; MIRIDAE; PORCINE CIRCOVIRUS 2; SUIDAE;

ANIMALS; CAPSID PROTEINS; CHROMATOGRAPHY, ION EXCHANGE; CIRCOVIRUS; NANOPARTICLES; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SWINE; TRANSFORMATION, GENETIC; VIRION;

EID: 84928136393     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.04.004     Document Type: Article

References (40)

1. Allan G.M., Ellis J.A. Porcine circoviruses: a review. J. Vet. Diagn. Invest. 2000, 12:3-14.
2. Bolin S.R., Stoffregen W.C., Nayar G.P., Hamel A.L. Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J. Vet. Diagn. Invest. 2001, 13:185-194.
3. Harms P.A., Sorden S.D., Halbur P.G., Bolin S., Lager K., Morozov I., Paul P.S. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus. Vet. Pathol. 2001, 38:528-539.
4. Segales J., Domingo M. Postweaning multisystemic wasting syndrome (PMWS) in pigs. A review. Vet. Q. 2002, 24:109-124.
5. Gillespie J., Opriessnig T., Meng X.J., Pelzer K., Buechner-Maxwell V. Porcine circovirus type 2 and porcine circovirus-associated disease. J. Vet. Intern. Med. 2009, 23:1151-1163.
6. Crowther R.A., Berriman J.A., Curran W.L., Allan G.M., Todd D. Comparison of the structures of three circoviruses: chicken anemia virus, porcine circovirus type 2, and beak and feather disease virus. J. Virol. 2003, 77:13036-13041.
7. Nawagitgul P., Morozov I., Bolin S.R., Harms P.A., Sorden S.D., Paul P.S. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J. Gen. Virol. 2000, 81:2281-2287.
8. Blanchard Ph., Mahe D., Cariolet R., Truong C., Le Dimna M., Arnauld C., Rose N., Eveno E., Albina E., Madec F., Jestin A. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome. Vet. Microbiol. 2003, 94:183-194.
9. Blanchard P., Mahe D., Cariolet R., Keranflec'h A., Baudouard M.A., Cordioli P., Albina E., Jestin A. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003, 21:4565-4575.
10. Trundova M., Celer V. Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells. Virus Genes 2007, 34:199-204.
11. Marcekova Z., Psikal I., Kosinova E., Benada O., Sebo P., Bumba L. Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies. J. Virol. Methods 2009, 162:133-141.
12. Wu P.-C., Lin W.-L., Wu C.-M., Chi J.-N., Chien M.-S., Huang C. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl. Microbiol. Biotechnol. 2012, 95:1501-1507.
13. Liu L.-J., Suzuki T., Tsunemitsu H., Kataoka M., Ngata N., Takeda N., Wakita T., Miyamura T., Li T.-C. Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus. Arch. Virol. 2008, 153:2291-2295.
14. Bucarey S.A., Noriega J., Reyes P., Tapia C., Saenz L., Zuniga A., Tobar J.A. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Vaccine 2009, 27:5781-5790.
15. Nainys J., Lasickiene R., Petraityte-Burneikiene R., Dabrisius J., Lelesius R., Sereika V., Zvirbliene A., Sasnauskas K., Gedvilaite A. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. BMC Biotechnol. 2014, 14:100.
16. Vicente T., Roldao A., Peixoto C., Carrondo M.J.T., Alves P.M. Large-scale production and purification of VLP-based vaccines. J. Invertebr. Pathol. 2011, 107:S42-S48.
17. Zeltins A. Construction and characterization of virus-like particles: a review. Mol. Biotechnol. 2013, 53:92-107.
18. Trible B.R., Suddith A.W., Kerrigan M.A., Cino-Ozuna A.G., Hesse R.A., Rowland R.R.R. Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2. J. Virol. 2012, 86:13508-13514.
19. Yin S., Sun S., Yang S., Shang Y., Cai X., Liu X. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli. Virol. J. 2010, 7:166.
20. Cook J.C., Joyce J.G., George H.A., Schultz L.D., Hurni W.M., Jansen K.U., Hepler R.W., Ip C., Lowe R.S., Keller P.M., Lehman E.D. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae. Protein Expr. Purif. 1999, 17:477-484.
21. Chahal P.S., Aucoin M.G., Kamen A. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J. Virol. Methods 2007, 139:61-70.
22. Baek J.-O., Seo J.-W., Kim I.-H., Kim C.H. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography. Protein Express. Purif. 2011, 75:211-217.
23. Wolff M.W., Siewert C., Hansen S.P., Faber R., Reichl U. Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnol. Bioeng. 2010, 107:312-320.
24. Gustavsson P.-E., Larsson P.-O. Superporous agarose, a new material for chromatography. J. Chromatogr. A 1996, 734:231-240.
25. Yao Y., Lenhoff A.M. Pore size distributions of ion exchangers and relation to protein binding capacity. J. Chromatogr. A 2006, 1126:107-119.
26. Yu M., Li Y., Zhang S., Li X., Yang Y., Chen Y., Ma G., Su Z. Improving stability of virus-like particles by ion-exchange chromatographic supports with large pore size: advantages of gigaporous media beyond enhanced binding capacity. J. Chromatogr. A 2014, 1331:69-79.
27. Jungbauer A., Hahn R. Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies. J. Chromatogr. A 2008, 1184:62-79.
28. Urbas L., Jarc B.L., Barut M., Zochowska M., Chroboczek J., Pihlar B., Szolajska E. Purification of recombinant adenovirus type 3 dodecahedric virus-like particles for biomedical applications using short monolithic columns. J. Chromatogr. A 2011, 1218:2451-2459.
29. Burden C.S., Jin J., Podgornik A., Bracewell D.G. A monolith purification process for virus-like particles from yeast homogenate. J. Chromatogr. B 2012, 880:82-89.
30. Hagel L., Ostberg M., Andersson T. Apparent pore size distributions of chromatography media. J. Chromatogr. A 1996, 743:33-42.
31. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
32. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
33. Wang K., Huang L., Kong J., Zhang X. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination. J. Virol. Methods 2008, 150:1-6.
34. Misinzo G., Delputte P.L., Meerts P., Lefebvre D.J., Nauwynck H.J. Porcine circovirus 2 uses heparin sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J. Virol. 2006, 80:3487-3494.
35. Williams A.M. Miscellaneous biospecific affinity gels. Protein Liquid Chromatography (Journal of Chromatography Library, vol 61) 1999, 731-764. Elsevier Science. 1st edition. M. Kastner (Ed.).
36. Brumfield S., Willits D., Tang L., Johnson J.E., Douglas T., Young M. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J. Gen. Virol. 2004, 85:1049-1053.
37. Branco L.M., Grove J.N., Geske F.J., Boisen M.L., Muncy I.J., Magliato S.A., Henderson L.A., Schoepp R.J., Cashman K.A., Hensley L.E., Garry R.F. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virol. J. 2010, 7:279.
38. Filipe V., Hawe A., Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm. Res. 2010, 27:796-810.
39. Kramberger P., Ciringer M., Štrancar A., Peterka M. Evaluation of nanoparticle tracking analysis for total virus particle determination. Virol. J. 2012, 9:265.
40. Papanikolaou E., Kontostathi G., Drakopoulou E., Georgomanoli M., Stamateris E., Vougas K., Vlahou A., Maloy A., Ware M., Anagnou N.P. Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation. Virus Res. 2013, 175:1-11.